Seventy-seven patients with first episodes of genital herpes and 111 with recurrent episodes were enrolled in a double-blind trial comparing topical acyclovir with a placebo (polyethylene glycol ointment). Among acyclovir-treated patients with first-episode primary genital herpes, the mean duration of viral shedding (4.1 days) and the time to complete crusting of lesions present at the initiation of therapy (7.1 days) were shorter than among placebo recipients (7.0 and 10.5 days, respectively) (P less than 0.05). Acyclovir-treated patients with recurrent herpes had a shorter duration of viral shedding than placebo recipients (0.95 vs. 1.90 days) (P = 0.03). Among the patients with recurrent herpes, acyclovir reduced the time to crusting of lesions in men but had no effect on the symptoms or healing times in women. Topical acyclovir shortens the duration of viral shedding and accelerates healing of some genital herpes simplex virus infections.
This article has been cited by other articles:
Cernik, C., Gallina, K., Brodell, R. T.
(2008). The Treatment of Herpes Simplex Infections: An Evidence-Based Review. Arch Intern Med
168: 1137-1144
[Abstract][Full Text]
Piret, J., Désormeaux, A., Cormier, H., Lamontagne, J., Gourde, P., Juhász, J., Bergeron, M. G.
(2000). Sodium Lauryl Sulfate Increases the Efficacy of a Topical Formulation of Foscarnet against Herpes Simplex Virus Type 1 Cutaneous Lesions in Mice. Antimicrob. Agents Chemother.
44: 2263-2270
[Abstract][Full Text]
Piret, J., Désormeaux, A., Gourde, P., Juhász, J., Bergeron, M. G.
(2000). Efficacies of Topical Formulations of Foscarnet and Acyclovir and of 5-Percent Acyclovir Ointment (Zovirax) in a Murine Model of Cutaneous Herpes Simplex Virus Type 1 Infection. Antimicrob. Agents Chemother.
44: 30-38
[Abstract][Full Text]
Mertz, G. J., Jones, C. C., Mills, J., Fife, K. H., Lemon, S. M., Stapleton, J. T., Hill, E. L., Davis, L. G., the Acyclovir Study Group,
(1988). Long-term Acyclovir Suppression of Frequently Recurring Genital Herpes Simplex Virus Infection: A Multicenter Double-blind Trial. JAMA
260: 201-206
[Abstract]
Rompalo, A. M., Mertz, G. J., Davis, L. G., Benedetti, J., Critchlow, C., Stamm, W. E., Corey, L.
(1988). Oral Acyclovir for Treatment of First-Episode Herpes Simplex Virus Proctitis. JAMA
259: 2879-2881
[Abstract]
WHITLEY, R. J.
(1988). Ganciclovir--Have We Established Clinical Value in the Treatment of Cytomegalovirus Infections?. ANN INTERN MED
108: 452-454
[Abstract]
DORSKY, D. I., CRUMPACKER, C. S.
(1987). Drugs Five Years Later: Acyclovir. ANN INTERN MED
107: 859-874
[Abstract]
Guinan, M. E.
(1986). Oral Acyclovir for Treatment and Suppression of Genital Herpes Simplex Virus Infection: A Review. JAMA
255: 1747-1749
[Abstract]
Marlowe, S. I.
(1985). Medical Management of Genital Herpes: Advances in Antiviral Treatment. Arch Dermatol
121: 467-470
[Abstract]
Becker, T. M., Blount, J. H., Guinan, M. E.
(1985). Genital Herpes Infections in Private Practice in the United States, 1966 to 1981. JAMA
253: 1601-1603
[Abstract]
Dolin, R
(1985). Antiviral chemotherapy and chemoprophylaxis. Science
227: 1296-1303
[Abstract]
Rubin, M. H., Ward, D. M., Painter, C. J.
(1985). Fulminant Hepatic Failure Caused by Genital Herpes in a Healthy Person. JAMA
253: 1299-1301
[Abstract]
Mertz, G. J., Critchlow, C. W., Benedetti, J., Reichman, R. C., Dolin, R., Connor, J., Redfield, D. C., Savoia, M. C., Richman, D. D., Tyrrell, D. L., Miedzinski, L., Portnoy, J., Keeney, R. E., Corey, L.
(1984). Double-blind Placebo-Controlled Trial of Oral Acyclovir in First-Episode Genital Herpes Simplex Virus Infection. JAMA
252: 1147-1151
[Abstract]
Koff, W., Fidler, I., Showalter, S., Chakrabarty, M., Hampar, B, Ceccorulli, L., Kleinerman, E.
(1984). Human monocytes activated by immunomodulators in liposomes lyse herpesvirus-infected but not normal cells. Science
224: 1007-1009
[Abstract]
JORDAN, M. C., JORDAN, G. W., STEVENS, J. G., MILLER, G.
(1984). Latent Herpesviruses of Humans. ANN INTERN MED
100: 866-880
[Abstract]
Laskin, O. L.
(1984). Acyclovir: Pharmacology and Clinical Experience. Arch Intern Med
144: 1241-1246
[Abstract]
Reichman, R. C., Badger, G. J., Mertz, G. J., Corey, L., Richman, D. D., Connor, J. D., Redfield, D., Savoia, M. C., Oxman, M. N., Bryson, Y., Tyrrell, D. L., Portnoy, J., Creigh-Kirk, T., Keeney, R. E., Ashikaga, T., Dolin, R.
(1984). Treatment of Recurrent Genital Herpes Simplex Infections With Oral Acyclovir: A Controlled Trial. JAMA
251: 2103-2107
[Abstract]
Whittington, W. L., Castes, W. J. Jr
(1984). Acyclovir Therapy for Genital Herpes: Enthusiasm and Caution in Equal Doses. JAMA
251: 2116-2117
[Abstract]
Solomon, A. R., Rasmussen, J. E., Varani, J., Pierson, C. L.
(1984). The Tzanck Smear in the Diagnosis of Cutaneous Herpes Simplex. JAMA
251: 633-635
[Abstract]
Sullivan-Bolyai, J., Hull, H. F., Wilson, C., Corey, L.
(1983). Neonatal Herpes Simplex Virus Infection in King County, Washington: Increasing Incidence and Epidemiologic Correlates. JAMA
250: 3059-3062
[Abstract]
Vince, R, Daluge, S, Lee, H, Shannon, W., Arnett, G, Schafer, T., Nagabhushan, T., Reichert, P, Tsai, H
(1983). Carbocyclic arabinofuranosyladenine (cyclaradine): efficacy against genital herpes in guinea pigs. Science
221: 1405-1406
[Abstract]
COREY, L., FIFE, K. H., BENEDETTI, J. K., WINTER, C. A., FAHNLANDER, A., CONNOR, J. D., HINTZ, M. A., HOLMES, K. K.
(1983). Intravenous Acyclovir for the Treatment of Primary Genital Herpes. ANN INTERN MED
98: 914-921
[Abstract]
COREY, L., ADAMS, H. G., BROWN, Z. A., HOLMES, K. K.
(1983). Genital Herpes Simplex Virus Infections: Clinical Manifestations, Course, and Complications. ANN INTERN MED
98: 958-972
[Abstract]
LAWRENCE, C., HOLMES, K. K.
(1983). Genital Herpes Simplex Virus Infections: Current Concepts in Diagnosis, Therapy, and Prevention. ANN INTERN MED
98: 973-983
[Abstract]
BALFOUR, H. H. JR.
(1983). Resistance of Herpes Simplex to Acyclovir. ANN INTERN MED
98: 404-406
[Abstract]
